Saito, N.; Hirai, N.; Aoki, K.; Suzuki, R.; Fujita, S.; Nakayama, H.; Hayashi, M.; Ito, K.; Sakurai, T.; Iwabuchi, S.
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma. Cancers 2019, 11, 121.
https://doi.org/10.3390/cancers11010121
AMA Style
Saito N, Hirai N, Aoki K, Suzuki R, Fujita S, Nakayama H, Hayashi M, Ito K, Sakurai T, Iwabuchi S.
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma. Cancers. 2019; 11(1):121.
https://doi.org/10.3390/cancers11010121
Chicago/Turabian Style
Saito, Norihiko, Nozomi Hirai, Kazuya Aoki, Ryo Suzuki, Satoshi Fujita, Haruo Nakayama, Morito Hayashi, Keisuke Ito, Takatoshi Sakurai, and Satoshi Iwabuchi.
2019. "The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma" Cancers 11, no. 1: 121.
https://doi.org/10.3390/cancers11010121
APA Style
Saito, N., Hirai, N., Aoki, K., Suzuki, R., Fujita, S., Nakayama, H., Hayashi, M., Ito, K., Sakurai, T., & Iwabuchi, S.
(2019). The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma. Cancers, 11(1), 121.
https://doi.org/10.3390/cancers11010121